Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilmour

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2007
AMPA receptor potentiation can prevent ethanol-induced intoxicationNicholas Jones, Marcus J Messenger, Michael J O'Neill, et al.
Neuroscience and Biobehavioral Reviews|May 3, 2012
Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery researchGary Gilmour, Alexander Arguello, Andrea Bari, et al.
The European Journal of Neuroscience|December 14, 2011
Close temporal coupling of neuronal activity and tissue oxygen responses in rodent whisker barrel cortexJennifer Li, Diego S Bravo, A Louise Upton, et al.
Molecular Psychiatry|December 2, 2022
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salienceMarios C Panayi, Thomas Boerner, Thomas Jahans-Price, et al.
Psychopharmacology|May 8, 2009
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophreniaGary Gilmour, Elsa Y Pioli, Sophie L Dix, et al.
Alzheimer'S Research & Therapy|September 22, 2017
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathyThomas Blackmore, Soraya Meftah, Tracey Karen Murray, et al.
Journal of Neuroscience Methods|December 1, 2010
Characterisation of carbon paste electrodes for real-time amperometric monitoring of brain tissue oxygenFiachra B Bolger, Stephen B McHugh, Rachel Bennett, et al.
Cell Reports|January 26, 2017
Coordinated Acetylcholine Release in Prefrontal Cortex and Hippocampus Is Associated with Arousal and Reward on Distinct TimescalesLeonor M Teles-Grilo Ruivo, Keeley L Baker, Michael W Conway, et al.
The European Journal of Neuroscience|February 11, 2017
The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout miceThomas Boerner, Alexei M Bygrave, Jingkai Chen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 21, 2020
The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brainCaterina Montani, Carola Canella, Adam J Schwarz, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2007
AMPA receptor potentiation can prevent ethanol-induced intoxicationNicholas Jones, Marcus J Messenger, Michael J O'Neill, et al.
Neuroscience and Biobehavioral Reviews|May 3, 2012
Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery researchGary Gilmour, Alexander Arguello, Andrea Bari, et al.
The European Journal of Neuroscience|December 14, 2011
Close temporal coupling of neuronal activity and tissue oxygen responses in rodent whisker barrel cortexJennifer Li, Diego S Bravo, A Louise Upton, et al.
Molecular Psychiatry|December 2, 2022
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salienceMarios C Panayi, Thomas Boerner, Thomas Jahans-Price, et al.
Psychopharmacology|May 8, 2009
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophreniaGary Gilmour, Elsa Y Pioli, Sophie L Dix, et al.
Alzheimer'S Research & Therapy|September 22, 2017
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathyThomas Blackmore, Soraya Meftah, Tracey Karen Murray, et al.
Journal of Neuroscience Methods|December 1, 2010
Characterisation of carbon paste electrodes for real-time amperometric monitoring of brain tissue oxygenFiachra B Bolger, Stephen B McHugh, Rachel Bennett, et al.
Cell Reports|January 26, 2017
Coordinated Acetylcholine Release in Prefrontal Cortex and Hippocampus Is Associated with Arousal and Reward on Distinct TimescalesLeonor M Teles-Grilo Ruivo, Keeley L Baker, Michael W Conway, et al.
The European Journal of Neuroscience|February 11, 2017
The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout miceThomas Boerner, Alexei M Bygrave, Jingkai Chen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 21, 2020
The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brainCaterina Montani, Carola Canella, Adam J Schwarz, et al.
Pageof 6